Tech Enhanced Investing

ITCONS E-Solutions is currently trading at RS. 512.00, up by 0.35 points or 0.07% from its previous close of RS. 511.65 on the BSE.

The stock opened at RS. 508.45 and touched an intraday high and low of RS. 512.00 and RS. 508.45 respectively, with 3200 shares traded so far.

A BSE group 'MT' stock with a face value of RS. 10, ITCONS has recorded a 52-week high of RS. 767.00 on September 25, 2024, and a 52-week low of RS. 49.22 on June 4, 2024. In the past week, the scrip’s high and low stood at RS. 549.00 and RS. 483.00 respectively. The company’s market capitalization is currently RS. 286.65 crore.

Promoter holding in the company stands at 59.54%, while institutional and non-institutional investors hold 0.38% and 40.08% respectively.

In a positive development, ITCONS E-Solutions has received a new work order from South East Central Railway, under the Ministry of Railways, Government of India. The company will provide two manpower resources to the Medical Department of the Raipur Division on a contractual basis for one year.

The total value of the contract is RS. 13.13 lakh, inclusive of all applicable taxes. This marks a key milestone for ITCONS and reinforces its association with Indian Railways.

Headquartered in New Delhi, ITCONS E-Solutions specializes in delivering human resource services across various sectors.

Jayshree Chemicals is currently trading at RS. 9.25, up by 0.42 points or 4.76% from its previous close of RS. 8.83 on the BSE.

The stock opened at RS. 9.25 and has touched a high of RS. 10.59 and a low of RS. 8.90 so far. A total of 1,54,848 shares have been traded on the counter.

This BSE group 'X' stock, with a face value of RS. 10, hit a 52-week high of RS. 12.00 on December 19, 2024, and a 52-week low of RS. 6.80 on April 7, 2025. In the last week, it traded between a high of RS. 10.59 and a low of RS. 7.15. The company currently has a market capitalization of RS. 26.69 crore.

The promoter holding in the company stands at 46.27%, while institutional and non-institutional holdings are at 0.71% and 53.02%, respectively.

In a recent board meeting held on April 24, 2025, Jayshree Chemicals approved the sale of its wind mill division, involved in wind power generation, as a going concern on a slump sale basis to M/s Vaishnav Infra. The sale, expected to be completed by June 2025, will fetch RS. 2.76 crore.

Jayshree Chemicals is primarily engaged in the production of chemicals such as caustic soda, chlorine, hydrochloric acid, sodium hydrosulphite, sulphur dioxide, and sulphuric acid, and operates in both the power and chemical segments.

RDB Infrastructure and Power is trading at RS. 55.00, up by 0.55 points or 1.01% from its previous close of RS. 54.45 on the BSE.

The stock opened at RS. 55.99 and touched an intraday high and low of RS. 55.99 and RS. 53.00, respectively. A total of 655 shares have been traded so far.

This BSE group 'X' stock, with a face value of RS. 1, hit a 52-week high of RS. 62.68 on April 4, 2025, and a 52-week low of RS. 13.67 on April 30, 2024. Over the past week, the stock has traded between RS. 57.54 and RS. 53.00. The company's current market capitalization stands at RS. 959.06 crore.

Promoter holding in the company is 70.42%, while institutional investors hold 0.29% and non-institutional investors hold 29.29%.

In a key development, RDB Infrastructure and Power has signed a Memorandum of Understanding (MoU) with Bigbull Infrabuild to develop a commercial/multi-storied retirement housing project. The project will be developed on company-owned land measuring 2.8375 acres in Village Palra, Sub-Tehsil Badshahpur, Gurgaon, Haryana. As per the agreement, RDB Infrastructure will receive 31.5% of the revenue, while Bigbull Infrabuild will receive 68.5%.

RDB Infrastructure and Power, formerly known as RDB Realty & Infrastructure, is primarily engaged in real estate development and related activities in India.

ACC is currently trading at RS. 1954.60, down by 113.40 points or 5.48% from its previous close of RS. 2068.00 on the BSE.

The stock opened at RS. 2068.05 and touched a high of RS. 2069.45 and a low of RS. 1937.50 so far. A total of 30,910 shares have been traded on the counter today.

This BSE group 'A' stock with a face value of RS. 10 had recorded a 52-week high of RS. 2843.00 on July 2, 2024, and a 52-week low of RS. 1778.80 on March 3, 2025. During the past week, it traded between RS. 2123.30 and RS. 1937.50. ACC's current market capitalization stands at RS. 36638.23 crore.

In terms of shareholding, promoters own 56.69% of the company, while institutions hold 29.90% and non-institutions 13.40%.

Financially, ACC reported a slight 1.76% decline in its standalone net profit to RS. 735.39 crore for the quarter ended March 31, 2025, compared to RS. 748.54 crore in the same quarter of the previous year. However, its total income grew by 12.32% to RS. 6199.44 crore in Q4FY25 from RS. 5519.62 crore a year earlier.

On a consolidated basis, the company saw a 20.39% drop in net profit to RS. 751.04 crore in Q4FY25, down from RS. 943.39 crore in the same quarter last year. Still, consolidated total income increased by 13.24% to RS. 6260.40 crore compared to RS. 5528.45 crore in Q4FY24.

For the full financial year ending March 31, 2025, ACC posted a 14.14% rise in standalone net profit at RS. 2424.56 crore, compared to RS. 2124.24 crore in FY24. Total income for the year increased by 11.17% to RS. 22726.73 crore from RS. 20443.74 crore.

On a consolidated basis for the same period, net profit rose marginally by 2.88% to RS. 2402.27 crore from RS. 2335.08 crore, while total income increased by 11.65% to RS. 22834.74 crore as against RS. 20451.77 crore in the previous financial year.

Axis Bank is currently trading at RS. 1152.25, down by 55.05 points or 4.56% from its previous closing of RS. 1207.30 on the BSE.

The stock opened at RS. 1183.95 and has touched an intraday high of RS. 1183.95 and a low of RS. 1149.00. So far, 2,42,360 shares have been traded on the counter.

Belonging to BSE group 'A', the bank’s stock with a face value of RS. 2 had touched a 52-week high of RS. 1339.55 on July 12, 2024, and a 52-week low of RS. 934.00 on January 27, 2025. In the past week, the scrip saw a high of RS. 1238.60 and a low of RS. 1149.00. The company’s current market capitalization stands at RS. 356942.45 crore.

The shareholding pattern includes 8.18% with promoters, 84.82% with institutions, and 7.00% with non-institutional investors.

Axis Bank reported a marginal 0.17% decline in standalone net profit at RS. 7117.50 crore for the quarter ended March 31, 2025, compared to RS. 7129.67 crore in the corresponding quarter of the previous year. However, its total income rose by 5.65% to RS. 38022.03 crore in Q4FY25 as against RS. 35990.33 crore in the same period last year.

On a consolidated basis, the bank posted a 1.63% fall in Q4FY25 net profit at RS. 7489.71 crore compared to RS. 7613.55 crore a year ago, while total income rose by 5.61% to RS. 39958.04 crore from RS. 37836.10 crore.

For the full financial year ended March 31, 2025, Axis Bank recorded a 6.08% increase in standalone net profit at RS. 26373.48 crore compared to RS. 24861.43 crore in FY24. Total income for the year rose by 12.23% to RS. 147934.10 crore from RS. 131810.59 crore in the previous year.

On a consolidated basis, annual net profit stood at RS. 28111.74 crore, up 6.38% from RS. 26423.54 crore in FY24, with total income increasing 12.99% to RS. 155916.86 crore from RS. 137989.36 crore.

Rajesh Power Services is trading at RS. 1260.00, up by 0.95 points or 0.08% from its previous close of RS. 1259.05 on the BSE.

The stock opened at RS. 1290.00 and touched an intraday high of RS. 1310.00 and a low of RS. 1235.00. A total of 44,800 shares have been traded so far.

Classified under BSE group 'M', the stock with a face value of RS. 10 hit its 52-week high of RS. 1290.00 on April 24, 2025, and a 52-week low of RS. 636.50 on December 2, 2024. Over the past week, the stock has seen a high of RS. 1290.00 and a low of RS. 971.35. The company's current market capitalization stands at RS. 2267.22 crore.

The promoter shareholding in the company is strong at 73.40%, with institutional investors holding 5.72% and non-institutional investors 20.88%.

Rajesh Power Services has recently bagged fresh orders worth RS. 1,116 crore from both government and institutional clients. The projects include turnkey contracts for supply, installation, testing, and commissioning of 11/22KV HT underground and overhead (MVCC) networks, 220/66kV GIS/AIS substations, and 132kV/66kV underground cables—all in Gujarat. These projects are expected to be completed within 12 to 18 months.

Rajesh Power Services (RPSL) is recognized as one of the country’s major players in underground power transmission and infrastructure EPC, with a strong foothold in the sector.

Samhi Hotels is currently trading at RS. 184.85, rising by 10.80 points or 6.21% from its previous close of RS. 174.05 on the BSE.

The stock opened at RS. 185.15 and recorded a high of RS. 186.85 and a low of RS. 180.20. A total of 2,36,723 shares have been traded so far.

Classified under BSE group 'A', the stock with a face value of RS. 1 has marked a 52-week high of RS. 225.60 on September 6, 2024, and a 52-week low of RS. 120.35 on April 7, 2025. Over the past week, it traded between RS. 186.85 and RS. 171.45. The company currently holds a market capitalization of RS. 4025.95 crore.

The institutional and non-institutional holdings in the company stand at 65.90% and 34.09%, respectively.

In a significant development, SAMHI Hotels has formed a strategic joint venture with GIC, a leading global institutional investor, to set up an investment platform for upscale and premium hotel assets in India. The joint venture will initially include five of SAMHI’s hotels—comprising over 1,000 rooms and valued at approximately RS. 2,200 crore—with GIC taking a substantial minority stake in the underlying SPVs.

These hotels are situated in high-demand office micro-markets in Bengaluru and Pune, areas with strong growth potential and limited new supply. The investment proceeds will be directed toward capital expenditure, new acquisitions, and reducing debt across the hotel portfolio. SAMHI will oversee the operation and development of all assets under the platform.

Through this partnership and capital infusion, SAMHI aims to strengthen its balance sheet and expand its hotel portfolio via its proven ‘category conversion’ strategy—acquiring, renovating, rebranding, and rerating hotels to drive growth.

Adani Green Energy is trading at RS. 957.80, up by 5.10 points or 0.54% from its previous close of RS. 952.70 on the BSE.

The stock opened at RS. 960.00 and recorded a high of RS. 962.70 and a low of RS. 953.00. A total of 90,325 shares have been traded so far.

Classified under BSE group 'A' and having a face value of RS. 10, the stock hit a 52-week high of RS. 2173.65 on June 3, 2024, and a 52-week low of RS. 758.00 on March 3, 2025. Over the past week, it has ranged between RS. 966.75 and RS. 925.90. The company's current market capitalization is RS. 151623.59 crore.

The shareholding pattern shows that promoters hold 60.94%, institutions 14.85%, and non-institutions 24.22%.

In a major development, Adani Green Energy’s wholly-owned step-down subsidiary, Adani Hydro Energy Five, has signed a Power Purchase Agreement (PPA) with Uttar Pradesh Power Corporation Limited (UPPCL) for supplying 1,250 MW of energy storage capacity through pumped hydro storage projects. The agreement was executed on April 23, 2025.

Adani Green Energy is engaged in building, owning, and operating renewable energy power plants, primarily based on solar and wind energy.

Lupin is currently trading at RS 2134.10, up by 45.25 points or 2.17% from its previous close of RS 2088.85 on the BSE.

The stock opened at RS 2087.90 and has touched an intraday high of RS 2135.70 and a low of RS 2085.00. A total of 9279 shares have been traded on the counter so far.

Belonging to the BSE group 'A', the stock with a face value of RS 2 has seen a 52-week high of RS 2403.45 (as on January 2, 2025) and a 52-week low of RS 1493.75 (as on June 4, 2024). Over the past week, the stock has fluctuated between RS 2139.00 and RS 1929.00. The company’s current market capitalization stands at RS 97047.47 crore.

Promoter holding in the company is at 46.92%, while institutions and non-institutions hold 46.88% and 6.20% respectively.

In a significant development, Lupin’s wholly owned subsidiary, Lupin Diagnostics (LDL), has secured 100% NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation across all its greenfield labs. This milestone underlines LDL’s stringent quality standards and its commitment to delivering reliable, high-quality diagnostic services. The accreditation reinforces the company's promise of accuracy and timeliness in patient diagnostics.

Lupin is a globally recognized, innovation-driven pharmaceutical company engaged in the production, development, and marketing of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs).

Panacea Biotec shares surged 5.00% to hit the upper circuit limit at RS. 538.90, rising by 25.65 points from its previous close of RS. 513.25 on the BSE.

The stock opened at RS. 524.05 and recorded an intraday high of RS. 538.90 and a low of RS. 520.15. A total of 35,427 shares have changed hands so far.

Classified under BSE group 'B', the stock with a face value of RS. 1 touched a 52-week high of RS. 549.05 on April 21, 2025, and a 52-week low of RS. 112.70 on June 4, 2024. Over the last week, the scrip traded between RS. 549.05 and RS. 496.85. The company's market capitalization currently stands at RS. 3294.07 crore.

The company’s shareholding pattern includes 72.48% held by promoters, 2.65% by institutions, and 24.87% by non-institutional investors.

The rally follows Panacea Biotec’s announcement of receiving an additional order from the United Nations International Children's Emergency Fund (UNICEF) for supplying 40 million doses of its bivalent oral polio vaccine (bOPV) in Q3CY2025. The order is valued at approximately $5.20 million (around RS. 44 crore).

Panacea Biotec is a prominent research-driven biotechnology company with robust capabilities in research, manufacturing, and marketing.